Cronos Unveils its New THCV Products: Spinach FEELZ™ Full Tilt
30 oct. 2023 07h00 HE
|
Cronos Group Inc.
TORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced the launch of two new THCV-infused products;...
Cronos Group Inc. to Hold 2023 Third Quarter Earnings Conference Call on November 8, 2023
25 oct. 2023 16h15 HE
|
Cronos Group Inc.
TORONTO, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 third quarter earnings conference call on Wednesday, November...
Cronos brand Spinach® Wins Best Pre-Roll at Grow Up Awards
05 oct. 2023 15h06 HE
|
Cronos Group Inc.
TORONTO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, is pleased to announce its Spinach® brand won “Best...
Cronos launches leading medical brand PEACE NATURALS® in Germany
18 sept. 2023 07h30 HE
|
Cronos Group Inc.
TORONTO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it shipped its first order of bulk cannabis, which will be...
Cronos Group Reports 2023 Second Quarter Results
08 août 2023 07h30 HE
|
Cronos Group Inc.
Industry-leading balance sheet with $841 million in cash and short-term investments Increased 2023 operating expense savings target to $20 to $25 million Announces additional initiatives to...
Cronos Group Inc. to Hold 2023 Second Quarter Earnings Conference Call on August 8, 2023
20 juil. 2023 09h00 HE
|
Cronos Group Inc.
TORONTO, July 20, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2023 second quarter earnings conference call on Tuesday, August 8,...
Cronos Group Inc. confirms receipt of unsolicited indications of interest
06 juil. 2023 17h28 HE
|
Cronos Group Inc.
TORONTO, July 06, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today confirmed that it has received a number of unsolicited indications of...
Cronos Group Inc. Announces Results of 2023 Annual Meeting of Shareholders
23 juin 2023 16h15 HE
|
Cronos Group Inc.
TORONTO, June 23, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announces that at its Annual Meeting of Shareholders held yesterday, June 22, 2023...
Cronos Group Announces Streamlined Operating Structure to Improve Cash Flow
31 mai 2023 16h50 HE
|
Cronos Group Inc.
Plans to Exit Existing U.S. hemp-derived CBD Operations Intends to Launch Lord Jones® Brand in the Canadian Adult-use Market in Q4 2023 TORONTO, May 31, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc....
Cronos Group Inc. to Speak at Bernstein's 39th Annual Strategic Decisions Conference
30 mai 2023 13h00 HE
|
Cronos Group Inc.
TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein,...